Urapidil D4

Capillary electrophoresis with end-column electrochemiluminescence for ultrasensitive determination of urapidil hydrochloride in rat plasma and its application to pharmacokinetics study
Shuangjiao Sun, Yanfen Wei, Chanjuan Long, Biyang Deng
Journal of Chromatography B Volume 1006, 1 December 2015, Pages 146-150
 
Development and validation of a simple uv spectrophotometric method for the determination of urapidil hydrochloride both in bulk and pharmaceutical formulation
S. Navgire , A. Ghadge , S. Gurav, S. G. Killedar and S. J. Nadaf
CIBTech Journal of Pharmaceutical Sciences 2016 Vol.5 (3) July-September, pp.10-15
 
Study on Determination of Related Substances of Urapidil Hydrochloride and Its Injection
LIU, Yu-zhen, NIE, Xin-yong, MI, Zhong-mao, ZHAO, Li-Ping
Chinese Journal of Pharmaceutical Analysis, Volume 25, Number 8, 1 August 2005, pp. 978-980(3)

Urapidil D4 is chemically 6-((3-(4-(2-Methoxyphenyl)piperazin-1-yl-2,2,6,6-d4)propyl)amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione. Urapidil D4 is supplied with detailed characterization data compliant with regulatory guideline. Urapidil D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Urapidil .

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.